fluconazole has been researched along with lactic acid in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Elliott, BR; Kartalija, M; Kaye, K; Liu, Q; Sande, MA; Täuber, MG; Tureen, JH | 1 |
| Espuelas, S; Irache, JM; Martinez-Oharriz, MC; Rivera, PA; Rubio, M | 1 |
| Evora, C; Martín, AY; Sánchez, E; Soriano, I | 1 |
| Fraga, GR; Kestenbaum, T; Machan, M | 1 |
| Alves, R; Casal, M; F Rodrigues, C; Henriques, M; Mota, S; P Brown, AJ; Paiva, S; Silva, S | 1 |
| Alanazi, AM; Jabeen, M; Khan, AA; Khan, S; Malik, A | 1 |
| Bernat, P; Krasowska, A; Muraszko, J; Suchodolski, J | 1 |
| Chou, YC; Hsu, YH; Lin, YT; Liu, SJ; Lu, CJ; Ueng, SW; Yu, YH | 1 |
9 other study(ies) available for fluconazole and lactic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Treatment of experimental cryptococcal meningitis with fluconazole: impact of dose and addition of flucytosine on mycologic and pathophysiologic outcome.
Topics: Animals; Antifungal Agents; Antigens, Fungal; Brain Edema; Cryptococcus neoformans; Drug Therapy, Combination; Fluconazole; Flucytosine; Lactates; Lactic Acid; Leukocyte Count; Meningitis, Cryptococcal; Rabbits | 1996 |
Fluconazole encapsulation in PLGA microspheres by spray-drying.
Topics: Antifungal Agents; Biocompatible Materials; Differential Thermal Analysis; Drug Carriers; Drug Compounding; Fluconazole; Lactic Acid; Microscopy, Electron, Scanning; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Surface Properties; X-Ray Diffraction | 2004 |
Biodegradable implantable fluconazole delivery rods designed for the treatment of fungal osteomyelitis: influence of gamma sterilization.
Topics: Animals; Antifungal Agents; Biocompatible Materials; Drug Delivery Systems; Fluconazole; Gamma Rays; Lactic Acid; Male; Mycoses; Osteomyelitis; Polyesters; Polymers; Rabbits; Sterilization | 2006 |
Diffuse hyperkeratosis in a deaf and blind 48-year-old woman--quiz case. Diagnosis: keratitis-ichthyosis-deafness (KID) syndrome with secondary dermatophytosis.
Topics: Antifungal Agents; Baths; Blindness; Deafness; Dermatologic Agents; Female; Fluconazole; Humans; Ichthyosis; Keratitis; Lactic Acid; Middle Aged; Ointments; Tinea; Trichophyton; Urea | 2012 |
The carboxylic acid transporters Jen1 and Jen2 affect the architecture and fluconazole susceptibility of Candida albicans biofilm in the presence of lactate.
Topics: Adaptation, Physiological; Antifungal Agents; Biofilms; Biofouling; Candida albicans; Carboxylic Acids; Cellular Microenvironment; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Glucose; Lactic Acid; Monocarboxylic Acid Transporters | 2017 |
Additive potential of combination therapy against cryptococcosis employing a novel amphotericin B and fluconazole loaded dual delivery system.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Synergism; Fluconazole; Lactic Acid; Male; Mice; Microbial Sensitivity Tests; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2018 |
Lactate Like Fluconazole Reduces Ergosterol Content in the Plasma Membrane and Synergistically Kills
Topics: Antifungal Agents; Candida albicans; Cell Membrane; Drug Resistance, Fungal; Drug Synergism; Ergosterol; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Glucose; Lactic Acid; Membrane Transport Proteins; Microbial Sensitivity Tests; Protein Transport | 2021 |
Sustained Release of Antifungal and Antibacterial Agents from Novel Hybrid Degradable Nanofibers for the Treatment of Polymicrobial Osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Ceftazidime; Delayed-Action Preparations; Fluconazole; Lactic Acid; Nanofibers; Osteomyelitis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Vancomycin | 2023 |